What does the evidence say about Milk Thistle Liver Disease Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Milk Thistle Liver Disease Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Silymarin, extracted from the seeds of Silybum marianum (milk thistle), has been utilised in traditional medicine for many years and is recognised for its neuroprotective and hepatoprotective properties. [Sayyad M (2025); evidence level 4] - Existing research reveals that silymarin has potent antioxidant and anti-inflammatory effects, coupled with anti-fibrotic, anti-carcinogenic, neuro-regenerative, and immunomodulatory actions, and has broad therapeutic relevance in both neurological and hepatic disorders, albeit with the drawback of low solubility. [Sayyad M (2025); evidence level 4] - This evidence is on four FDA-recognized (Food and Drug Administration) medicinal plants. [Burdan O (2025); evidence level 4] - Endometriosis involves oestrogen-dependent chronic inflammation and the abnormal proliferation of ectopic endometrial tissue. [Burdan O (2025); evidence level 4] - Conventional hormonal therapies suppress systemic oestrogen, but do not fully address local oxidative and inflammatory signalling. [Burdan O (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.